The Journal of Experimental Medicine · 2007 · 668 citations · 43 references
MedicineDermatologyImmunologyImmunopathologyImmunotherapyInflammationInflammatory DermatosesInflammatory Skin DiseasesInflammatory Skin DisordersInterleukin 17 InhibitionInterleukin-17 PathwayInterleukin-17 ResponsesT Helper 17 DifferentiationTh17 Cell DifferentiationTh17 Effector FunctionTh17 Responses
Biological agents have dramatically improved treatment options for patients with severe psoriasis. Etanercept (tumor necrosis factor [TNF] receptor-immunoglobulin fusion protein) is an effective treatment for many psoriasis patients, and blockade of TNF is considered to be its primary action. However, in this clinical trial, we show that etanercept has early inhibitory effects on a newly appreciated type of T cells: T helper type 17 (Th17) cells. Etanercept reduced the inflammatory dendritic cell products that drive Th17 cell proliferation (interleukin [IL] 23), as well as Th17 cell products and downstream effector molecules (IL-17, IL-22, CC chemokine ligand 20, and beta-defensin 4). In contrast, Th1 cellular products and effector molecules (interferon gamma, lymphotoxin alpha, and myxovirus resistance 1) were reduced late in disease resolution. This study suggests a role for Th17 in addition to Th1 cells in the pathogenesis of psoriasis. Th17 cells may be particularly important in driving epidermal activation in psoriatic plaques, whereas Th1 cells must also be eliminated for final disease resolution.
43
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Heon Park, Zhaoxia Li, Xuexian O. Yang et al. · Nature Immunology · 2005 · 4.2K citations · Full text
Transforming growth factor-β induces development of the TH17 lineage
Paul R. Mangan, Laurie E. Harrington, Darrell B. O’Quinn et al. · Nature · 2006 · 3K citations
Phenotypic and functional features of human Th17 cells
Francesco Annunziato, Lorenzo Cosmi, Veronica Santarlasci et al. · The Journal of Experimental Medicine · 2007 · 1.8K citations · Full text
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Yan Zheng, Dimitry M. Danilenko, Patricia Valdez et al. · Nature · 2006 · 1.8K citations
Life Sciences, Immunology, Pathology +14